• Home
  • Visum Pharmaceutical Co., Ltd
16
Jun
2027
National Exhibition and Convention Center
16 Jun 2027 - 18 Jun 2027
stand 82F92
Book a meeting

Visum Pharmaceutical Co., Ltd

  • Visum Pharmaceutical
About Visum Pharmaceutical Co., Ltd

Visum pharmaceutical is an US FDA & China NMPA approved pharmaceutical company located in Hainan, China, specialized in developing and manufacturing various pharmaceutical products including generics/OTCs/Innovative drugs in oral solids, half-solids, liquids of final dosages. 

Two generic drugs have been launched in US and are looking for global distributors. 


We also provide CDMO/CMO services for international partners with global regulatory compliance.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI & PMEC China 2027

    CPHI & PMEC China 2027

    National Exhibition and Convention Center
    16 Jun 2027 - 18 Jun 2027
    stand 82F92
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
Show contact info Hide contact info

Products from Visum Pharmaceutical Co., Ltd (7)

  • Analytical Method Develpment and Validation

    Product Analytical Method Develpment and Validation

    Providing Analytical method development, validation and stability study from Phase I-III to commercial prodcution and registration.
  • CDMO- Generics/OTCs in Tablets, Capsules, Granules...

    Product CDMO- Generics/OTCs in Tablets, Capsules, Granules...

    FDA approved facility in China providing Contract Development and Manufacturing Services in Various Dosage Forms: • Tablets • Capsules • Granules/Powder for OS • Oral Solutions • Drops • Ointment • Cream • Gel

    Applicable for most generics/OTCs and innovative drugs.
  • Clinical Supply Manufacturing

    Product Clinical Supply Manufacturing

    NCEs • Phase I-III formulation process development and clinical supply manufacturing Generic drugs
    • BE sample manufacturing • Process Optimization
  • Commercial Manufacturing (CMO)

    Product Commercial Manufacturing (CMO)

    Standards: • US, EU, China, WHO Commercial Scales
    • Tablets: 3 billion/year • Capsules: 500 million/year • Oral solution: 100 million/year • Ointment: 50 million/year • Granules: 300 million/year
  • Formulation Development

    Product Formulation Development

    NCEs • Phase I-III formulation and development Generic Drugs • Pharmaceutical, analytical method development and process study
  • Metoprolol Succinate Extended-Release Tablets

    Product Metoprolol Succinate Extended-Release Tablets

    Metoprolol Succinate Extended-Release Tablets is a beta 1-selevitve adrenoceptor blocking agent, which can  reduce heart rate, myocardial contractility, blood pressure, antagonize the toxicity of catecholamine adreneric transmitters, and has good cardiovascular protection. It is widely used in cardiov...
  • Paroxetine Extended-Release Tablets

    Product Paroxetine Extended-Release Tablets

    For the treatment of Major Depressive Disorder (MDD), Panic Disorder (PD), Social Anxiety Disorder (SAD) and Premenstrual Dysphoric Disorder (PMDD).